AAUM (Average Assets Under Management) of ₹119.47 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 99.5% | 99.9% | ▲ +0.4% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 99.9% | 100.0% | ● +0.0% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Weight (Jul 2026) |
|---|---|---|---|
| 1 | Sai Life Sciences Limited ₹2.72 Cr |
Pharmaceuticals & Biotechnology | 1.84% |
| # | Stock | Sector | Last Weight (Jun 2026) |
|---|---|---|---|
| 1 | JB Chemicals & Pharmaceuticals Limited ₹2.76 Cr |
Pharmaceuticals & Biotechnology | 2.03% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹11.25 Cr |
Pharmaceuticals & Biotechnology | 5.24% | 7.60% | +2.36% |
| 2 | Divi's Laboratories Limited ₹15.33 Cr |
Pharmaceuticals & Biotechnology | 9.04% | 10.36% | +1.32% |
| 3 | Laurus Labs Limited ₹10.58 Cr |
Pharmaceuticals & Biotechnology | 6.38% | 7.15% | +0.77% |
| 4 | Piramal Pharma Limited ₹1.82 Cr |
Pharmaceuticals & Biotechnology | 1.13% | 1.23% | +0.10% |
| 5 | Abbott India Limited ₹2.16 Cr |
Pharmaceuticals & Biotechnology | 1.43% | 1.46% | +0.03% |
| 6 | Sun Pharmaceutical Industries Limited ₹31.56 Cr |
Pharmaceuticals & Biotechnology | 21.31% | 21.33% | +0.02% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Dr. Reddy's Laboratories Limited ₹10.48 Cr |
Pharmaceuticals & Biotechnology | 8.94% | 7.08% | -1.86% |
| 2 | Cipla Limited ₹12.41 Cr |
Pharmaceuticals & Biotechnology | 8.91% | 8.39% | -0.52% |
| 3 | Lupin Limited ₹8.78 Cr |
Pharmaceuticals & Biotechnology | 6.35% | 5.94% | -0.41% |
| 4 | Aurobindo Pharma Limited ₹6.55 Cr |
Pharmaceuticals & Biotechnology | 4.72% | 4.43% | -0.29% |
| 5 | Mankind Pharma Limited ₹4.19 Cr |
Pharmaceuticals & Biotechnology | 3.11% | 2.83% | -0.28% |
| 6 | Glenmark Pharmaceuticals Limited ₹5.04 Cr |
Pharmaceuticals & Biotechnology | 3.59% | 3.40% | -0.19% |
| 7 | Biocon Limited ₹4.55 Cr |
Pharmaceuticals & Biotechnology | 3.23% | 3.07% | -0.16% |
| 8 | Zydus Lifesciences Limited ₹4.22 Cr |
Pharmaceuticals & Biotechnology | 3.01% | 2.85% | -0.16% |
| 9 | Gland Pharma Limited ₹2.99 Cr |
Pharmaceuticals & Biotechnology | 2.15% | 2.02% | -0.13% |
| 10 | Alkem Laboratories Limited ₹5.04 Cr |
Pharmaceuticals & Biotechnology | 3.52% | 3.40% | -0.12% |
20 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹31.56 Cr |
Pharmaceuticals & Biotechnology |
21.33%
|
|
| 2 |
₹15.33 Cr |
Pharmaceuticals & Biotechnology |
10.36%
|
|
| 3 |
₹12.41 Cr |
Pharmaceuticals & Biotechnology |
8.39%
|
|
| 4 |
₹11.25 Cr |
Pharmaceuticals & Biotechnology |
7.60%
|
|
| 5 |
₹10.58 Cr |
Pharmaceuticals & Biotechnology |
7.15%
|
|
| 6 |
₹10.48 Cr |
Pharmaceuticals & Biotechnology |
7.08%
|
|
| 7 |
₹8.78 Cr |
Pharmaceuticals & Biotechnology |
5.94%
|
|
| 8 |
₹6.55 Cr |
Pharmaceuticals & Biotechnology |
4.43%
|
|
| 9 |
₹5.04 Cr |
Pharmaceuticals & Biotechnology |
3.40%
|
|
| 10 |
₹5.04 Cr |
Pharmaceuticals & Biotechnology |
3.40%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.